Human embryonic stem cells (hESCs) can be induced to differentiate towards hematopoiesis with high efficiency. In this work, we analyzed the methylation status of the X-linked HUMARA (human androgen receptor) gene in hematopoietic cells derived from hESC line H9 before and after induction of hematopoietic differentiation. All passages of H9 and H9-derived hematopoietic cells displayed homogenous methylation pattern with disappearance of the same allele upon HpaII digestion. This pattern persisted in the great majority of different hematopoietic progenitors derived from H9, except in 11 of 86 individually plucked colonies in which an equal digestion of the HUMARA alleles has been found, suggesting that a methylation change occurring at this locus during differentiation. Interestingly, quantification of X inactive-specific transcript (XIST) RNA in undifferentiated H9 cell line and day 14 embryoid bodies (EB) by RT -PCR did not show any evidence of XIST expression either before or after differentiation. Thus, during self-renewal conditions and after induction of commitment towards the formation of EB, the methylation pattern of the HUMARA locus appears locked with the same unmethylated allele. However, hematopoietic differentiation seems to be permissive to the reversal of methylation status of HUMARA in some terminally differentiated progenitors. These data suggest that monitoring methylation of HUMARA gene during induced differentiation could be of use for studying hESC-derived hematopoiesis.
Introduction
Since their first isolation in 1998 (Thomson et al., 1998) human embryonic stem cells (hESCs) have opened a major area of investigation in almost all fields of medicine, from developmental studies to drug discovery purposes (Pouton et al., 2007) .
They are also a promising tool for regenerative medicine applications, due to their major proliferative potential and their persistent differentiation ability towards several tissues, under the influence of optimal cues (Klimanskaya et al., 2008) . However, the future clinical use of hESCs depends on the development of efficient and complete differentiation protocols as well as on the ability to develop methods evaluating the potential of induction of malignancies. The genomic stability of hESCs is one of the critical requirements for their potential clinical use (Lefort et al., 2008) . More recently, it became also clear that the epigenetic status of the pluripotent cells needs to be optimally controlled before the development of clinically applicable procedures (Pannetier et al., 2007) . Indeed, the epigenetic status of hESCs needs to be carefully assessed during differentiation programs.
X-chromosome inactivation (XCI) is a highly regulated gene compensation process by which one of the X chromosomes undergoes inactivation in females at very early stages of embryonic development (Heard et al., 1997) . The major role of the cis-acting X inactive-specific transcript (XIST) gene in this process is now well-established. Mechanistically, the transcription of XIST plays a major role in XCI by coating the X-chromosome which is to be silenced. The XCI process is essentially random in humans with inactivation of either paternal (Xp) or maternal (Xm)-derived X-chromosome and persists in adult life, generating the XCI mosaicism in normal female tissues. This process is further 'locked' by methylation, on the inactive X-chromosome, of CpG islands present in the promoters of several genes (Heard, 2004) .
The analysis of XCI in hESCs has been performed in several cell lines essentially using the expression of XIST transcript by RT-PCR or by RNA fluorescence in situ hybridization (FISH) (Hoffman et al., 2005; Shen et al., 2008; Silva et al., 2008) . In contrast to mouse ES cells, an important heterogeneity has been reported regarding the XCI status in hESCs. It has been shown that some cell lines can up-regulate XIST and undergo XCI upon differentiation like in the mouse. Others, however, have already undergone XCI and express high levels of XIST in their undifferentiated state. More strikingly, a third class of hESCs carries an inactive X-chromosome but has lost XIST expression (Silva et al., 2008) . This observation reveals that, in hESCs at least, X-inactivation can be maintained in the absence of XIST. It also indicates that XIST expression cannot be used as a hallmark for XCI. It is therefore important to develop an alternative approach to easily assess XCI status of hESCs at different loci.
The X-linked gene HUMARA (human androgen receptor) is an interesting candidate for this analysis as it has been extensively used to demonstrate and to follow clonality of hematopoiesis in females with hematopoietic malignancies (Delabesse et al., 1995; Guan et al., 2002; Bohm et al., 2003; Bumm et al., 2003) . In an hESC line which has already undergone XCI, clonal analysis can not be performed but methylation analysis can be a useful tool to detect changes occurring during different steps of differentiation from hESCs towards terminal stages of hematopoiesis.
To our knowledge there has been no study describing this analysis in hESCs. We report here that the methylation status of HUMARA remains stable during several stages of differentiation from the hESC stage through embryoid bodies (EB) and hematopoiesis. However, changes in the pattern of HUMARA methylation and likely of XCI can occasionally occur in hematopoietic progenitors, suggesting a permissivity of the hematopoietic context for this event.
Results
The first goal of the study was to determine if the hESC lines of female origin could be informative for methylation analysis of an X-linked gene such as phosphoglycerate kinase (PGK) or HUMARA, which are commonly used for clonality analyses in hematopoietic malignancies (Delabesse et al., 1995; Guan et al., 2002; Bohm, et al., 2003; Bumm et al., 2003) . For this purpose, we have screened two female hESC lines, H9 and HUES9, at the PGK and HUMARA loci. Neither of these cell lines was informative for PGK analysis due to the absence of BstXI site required for the separation between Xp and Xm ( Figure 1) . As can be seen in this figure, BstXI polymorphic site was absent in the cell lines H9 (lane 1) and HUES9 (lanes 2 and 3) whereas in two positive control samples from two female patients with leukemia, the use of BstXI restriction enzyme generated two bands, of 530 and 433 bp demonstrating the presence of a BstXI site in one of the alleles (lanes 4 and 5). Methylation analysis could therefore not be performed using PGK gene locus in H9 and HUES9 cell lines. We then decided to explore the possibility of using HUMARA locus to separate Xm and Xp. Using this analysis, both cell lines exhibited a differential number of CAG repeats at the HUMARA locus, allowing the separation between Xm and Xp, but in the HUES9 cell line, this differential number was only a single CAG triplet, which did not allow a reliable separation of two alleles. On the other hand, in the H9 cell line, the Xp and Xm could be amplified with a differential number of six base repeats between them, suggesting that the methylation analysis could be reliably performed.
We first analyzed the H9 cell line which had been cultured using several passages in the presence of mouse embryonic fibroblasts (MEF). Figure 2 summarizes the experimental strategy that we undertook in order to study the methylation status of HUMARA in the H9 cell line. In preliminary experiments, we have shown that human HUMARA primers do not yield any amplification from murine embryonic fibroblasts ( Figure 3A) . In these conditions, the H9 cell line displayed a reproducible methylation pattern with a homogenous distribution of methylated and unmethylated alleles, with the complete digestion of an allele that we have arbitrarily designed as 'allele b'. The relative corrected index (RCI) of all passages analyzed (31-84) yielded a value .10 (5 passages out of 6), suggesting the presence of a complete or near complete hypomethylation of the allele b, which generated the pattern shown ( Figure 3B , Table 1 ). In cultures split by mechanical passages, the analysis was performed using the bulk of cells recovered from the cultures. We have therefore asked whether single hESC clones generated from H9 cells would display a similar methylation pattern of the b allele. Single-cell cloning of hESCs has been found to be very difficult due to the fact that cells grow in tight colonies, and cannot readily be dissociated into single cells without a high level of apoptotic activity due to anoikis (Watanabe et al., 2007) . For the purpose of single-cell cloning, we have used a subclone of H9 cell line which has been adapted for single-cell growth. Using this subclone of H9, limiting dilution experiments were possible and allowed us to analyze the methylation status of the HUMARA locus in individual H9 clones. In 11 individual sub-lines that we have analyzed, the methylation pattern generated was similar to the 'bulk' H9 cultures with complete (1 of 11) or near complete digestion of allele b (10 of 11) with a mean RCI value of 8 (range 5.8-14.4) ( Table 1) . Altogether, these results suggest that XCI has already been established in this H9 sub-line and further confirm the previously reported non-random pattern of XCI in H9 (Shen et al., 2008) . In agreement with this, methylation of the HUMARA locus remained the same during H9 differentiation into EB, with either a complete or near complete digestion of the same allele ( Figure 3B , Table 1 ).
In order to gain further insight into the X-inactivation status of our H9 sub-lines, we analyzed by RT-PCR the expression of XIST. XIST is the master locus of the X-inactivation process, which produces a non-coding RNA that coats the chromosome in cis and induces its silencing. High levels of XIST expression are systematically associated with XCI. In contrast, X-inactivation can be maintained in the absence of XIST expression, as recently shown in some hESC lines (Shen et al., 2008; Silva, et al., 2008) . As shown in Figure 4 , XIST expression in H9 cells is very low and reaches levels that are comparable with that of a male cell line, used here as a negative control. This is in striking contrast to results obtained in another female cell line, HUES9, which displays 1000-fold enrichment in XIST RNA levels compared with H9. Importantly, XIST expression in H9 did not increase during differentiation towards EB ( Figure 4A ). To confirm the presence of an inactive X-chromosome in the absence of XIST expression in H9, we have performed an RNA-FISH analysis of XIST and CHIC1, an X-linked gene subjected to X-inactivation ( Figure 4B ). In the female control IMR-90 cell line which has undergone XCI, a single spot of CHIC1 co-exists along with a cloud of XIST, which reveals the presence of an active and inactive X respectively. In contrast, in the H9 cell line, no XIST signal could be detected although a single CHIC1 spot was present ( Figure 4B) . These results strongly suggest that X-inactivation has been completed in our H9 sub-lines and that XIST has been subsequently silenced, likely through epigenetic regulation. In agreement with this, we found substantial levels of DNA methylation across XIST exon 1 CpG island, as shown in Figure 4C . We then asked whether the methylation status of HUMARA remains stable during hematopoietic differentiation of H9 cells (Figure 2 ). For this purpose we have used hematopoietic progenitors as well as bulk hematopoietic cells generated in OP9 cultures from H9 cell line. For progenitor analysis, single colony-forming unit granulocyte-macrophage (CFU-GM) or burst-forming unit erythroid (BFU-E) was plucked from methylcellulose cultures and HUMARA analysis was performed after DNA extraction. As seen in Table 1 , a total of 86 individual hematopoietic progenitors were analyzed using this technique. In the great majority of the individual progenitors (75 of 86) there was either a total or near total digestion of allele b, with an RCI . 10 in 44 colonies. RCI was . 2 and ,10 in 31 colonies. These cells had therefore clearly presented a skewed methylation at the HUMARA locus, with always the same allele being undermethylated.
Strikingly, we have found 11 colonies (13%) in which the digestion of the b allele was equal to that of allele a, with an RCI , 2 ( Figure 3B and Table 1 ). Given the fact that we were in clonal conditions using single colony-forming unit-cell (CFU-C), this pattern could be due to either the plucking of two colonies with differential methylation of the b allele or the alteration of the methylation of allele b at the HUMARA locus during single colony growth. In both cases, this would be consistent with the reappearance of cells with a modified methylation pattern during hematopoietic differentiation. These data may reflect a plasticity of XCI in hematopoietic precursors, as this has been previously suggested in the mouse (Savarese et al., 2006) .
Discussion
The status of XCI in hESCs has been the subject of several studies, some of which generated controversial results (Dhara et al., 2004; Hoffman et al., 2005; Savarese, et al., 2006; Shen et al., 2008) . Different patterns of XCI have been found in different cell lines and also in different sub-culture of the same cell line (Tanasijevic et al., 2009) , suggesting a flexibility in the XCI process in hESC lines. Importantly, in hESCs XIST expression does not always correlate with XCI (Class III hESCs) and other approaches need to be used in order to assess the X-inactivation status of the cells. The relationship between expression -inactivation and the methylation of CpG islands at several genes has been demonstrated, but to our knowledge there has been no study with regard to the methylation of HUMARA gene in female hESC lines. Our results suggest that this methylation is highly stable in this cell line during self-renewal conditions but prone to modification during hematopoietic differentiation, essentially in hematopoietic progenitors. We have observed the reversal of this methylation pattern in 13% of individual colonies analyzed, with a clear alteration of the balance between methylation of both alleles of the HUMARA gene. The significance of this phenomenon remains to be determined, but some degree of permissiveness of hematopoietic precursors for XCI has been previously reported in mice using tetracycline-inducible XIST alleles (Savarese et al., 2006) . More recently, this specific hematopoietic context for gene silencing has been confirmed in lymphoma cells (Agrelo et al., 2009) . Our results suggest that in the context of hematopoietic cells derived from hESCs, the methylation status of some X-linked genes such as HUMARA can be modified as this has been documented in mouse (Savarese et al., 2006) or human lymphoma cells (Agrelo et al., 2009 ) but overall, the epigenetic status of the HUMARA gene remains stable. Moreover, our findings suggest that the methylation analysis of the HUMARA gene is stable in H9 cell line. These data suggest that evaluation of the methylation status of HUMARA could be a simple and rapid method to evaluate the epigenetic status of female pluripotent stem cell lines and their differentiated progeny.
Materials and methods

Human ES cell culture
After authorization of the French Biomedicine Agency, hESC lines H1 and H9 (WiCell Research Institute, USA) and HUES9 (Doug Melton, Harvard) were imported and cultured on mitomycin-treated mouse embryonic fibroblast cells in Knockout DMEM medium supplemented with 20% Knockout serum replacement (Invitrogen), 1% non-essential amino acids, 1 mM L-glutamine, 0.1 mM b-mercaptoethanol (Sigma) and 5 ng/ml bFGF (Invitrogen). The medium was changed daily and cells were passaged weekly with collagenase type IV (Invitrogen) by scrapping to obtain small clumps. H9 and HUES9 cell lines were used at different passages.
Cloning H9 cells
To obtain clonal colonies of hESCs, the H9 cell line was first progressively adapted to single-cell passaging, as described previously (Chan et al., 2008) , to increase plating efficiency and clonal recovery. H9 hESCs were cultured on mitomycin C inactivated MEF and passaged weekly using collagenase IV. Upon passage 35, TrypLE Express (Invitrogen) was used to dissociate the H9 cells to single cells. Cells were subsequently passaged using TrypLE Express for 6 passages. To recover clonal colonies of H9 cells, 20 000 TrypLE-adapted H9 cells were then placed on MEF, and 18 colonies were manually recovered 8 days later and plated on new MEF.
Generation of EB
For EB formation, on the day of passage, the hESCs were treated with collagenase, and the small clumps were then cultured in Iscove's modified Dulbecco's medium (IMDM, Invitrogen) supplemented with 15% fetal calf serum, 450 mM monothioglycerol, 50 mg/ml ascorbic acid (Sigma), 200 mg/ml transferrin (Sigma) in the presence of the following cytokines: stem cell factor and the class III receptor tyrosine kinase ligand (Flt3-L) at 100 ng/ml and trombopoietin at 50 ng/ml. All cultures were incubated at 378C in normoxic conditions and 5% CO 2 . Under these conditions, hESCs give rise to EB cultured for 14 days.
Differentiation of hESCs in co-culture with OP9 cells
For hESCs differentiation we used OP9 co-culture method described by Vodyanik et al. (2005) . Briefly, OP9 cell lines (ATCC) were plated onto gelatinized dishes in aMEM medium without ribonucleotides and desoxyribonucleotides (Invitrogen) supplemented with 10% fetal bovine serum and 100 mM monothioglycerol at 1.2 × 10 6 cells per 100-mm 2 dish after 3-4 days cells are confluent and half of the medium was changed. After 3 or 4 days, clumps of undifferentiated hESCs were added at equivalent to 1.5 × 10 6 cells per dish in the same medium. At days 4, 6 and 8 half of the medium was changed and cells were cultured for 13 days.
At day 13 for differentiation into OP9 cells and day 14 for differentiation by EB, cells harvested by mechanical dissociation by gentle pipetting in phosphate buffered saline (PBS) and used either DNA extraction or hematopoietic clonogenic progenitor assay. Hematopoietic clonogenic progenitor assay cells from hESCs co-culture with OP9 or EB were plated at 1 × 10 5 cells/ml into MethoCult GF (StemCell Technologies). Hematopoietic colonies were counted at day 14 and harvested individually (BFU-E, CFU-GM and CFU-G and CFU-M) for DNA extraction.
DNA extraction
Cells were lysed in Tris, Nacl, EDTA buffer containing 0.1% SDS and digested with proteinase K, and DNA extraction was performed using phenol-chloroform followed by precipitation using standard techniques (Delabesse et al., 1995) .
RNA extraction and XIST analyses
Cell pellets were lysed in TRIzol (Invitrogen) and RNA extracted according to the manufacturers recommendation. RNA quality was assessed by electrophoresis on an Agilent Bioanalyzer. Random-primed reverse transcription (RT) was performed on 1 mg of denatured total RNA in a 50 ml reaction volume using the SuperScript II reverse transcriptase (Invitrogen). Control RT reactions lacking reverse transcriptase (RT-): reactions were systematically run for all samples. Real-time PCR was performed using SYBR Green PCR mix (Applied Biosystems) and Mxpro3000 (Stratagene) at the following thermal cycling parameters: 10 min 958C, 50 cycles (15 sec at 958C, 1 min at 608C). Five microliters of DNA were used in each reaction.
All primer sets were tested for the optimal concentration in PCR reaction then checked for the absence of unspecific amplification. Results were normalized using b2-microglobulin (B2M) primers in order to control for sample variation. Primer sequences were as follows: XIST sense primer ( 
Methylated DNA immunoprecipitation
To perform the methylated DNA immunoprecipitation (MeDIP) assay, H9 and HUES9 ES cell genomic DNA was sonicated to a size range of 300 -1000 bp. Monoclonal antibody against 5 ′ -methylcytidine (Eurogentec # MMS-900P-B) was used to immunoprecipitate 5 mg of denatured DNA and incubated O/N with overhead shaking at 48C. Antibody/methylated DNA complexes were collected by the addition of G protein Sepharose beads (Sigma Aldrich cat# P3296). The MeDIP assay was performed three times on independent DNA preparations to control for sample variation. Initial sonicated genomic DNA was used as the input (INP) and compared with the IP DNA in real-time PCR quantification. To assess the enrichment of each target genomic region after IP, we calculated the ratio between the average value obtained for the IP DNA and the average value obtained for the corresponding input, both values being first normalized for dilution factors. Results were represented as percentages of enrichment. Each PCR was run in triplicates.
RNA fluorescence in situ hybridization
ES cells and MEFs cultured on coverslips were permeabilized in 1× PBS/0.5% Triton X-100/2 mM Vanadyl Ribonucleoside Complex (Biolabs) on ice for 7 min, fixed with 3% paraformaldehyde for 10 min, and progressively dehydrated in ethanol. For XIST RNA detection, a 10 kb DNA probe (XIST plasmid G1A) was labeled with FITC using the bioprime random priming kit (Invitrogen, Cergy Pontoise. France). For CHIC1 RNA detection, the human BAC RP11-454G19 was obtained from BACPAC (Oakland, CA, USA) and labeled with Alexa Fluor 568nm (Invitrogen) using the same kit. Cells were then hybridized with probes overnight at 378C in a dark and humid chamber. The next day, after three washes in 50% formamide/2× SSC at 428C, three washes in 2× SSC at 428C, coverslips were mounted on slides in Vectashield containing DAPI and visualized under fluorescent microscope. This protocol is detailed on the Epigenome Network of Excellence Web site (http://www .epigenome-noe.net/researchtools/protocol.php?protid=3).
PGK gene analyses
To determine the presence of an informative polymorphic marker on the PGK gene, DNA extracted from H9 and HUES9 cell lines was amplified using PGK primers and the PCR product was digested by 15 U of BstXI at 558C overnight as previously described .
HUMARA analyses
This analysis was performed according to a previously published procedure (Delabesse et al., 1995) . Briefly, to screen for HUMARA informativity of a given hESC line we have used a single step PCR using 0.5-1 mg of DNA which was amplified using 5 ′ and 3 ′ primers encompassing the polymorphic HUMARA locus, using an FITC-labeled sense primer (5 ′ -GTG CGC GAA GTG ATC CAG AAC C-3 ′ ) and an antisense primer (5 ′ -TAC GAT GGG CTT GGG GAG AAC C-3 ′ ). PCR was performed with a denaturation step at 948C, followed by an annealing step at 658C; this sequence was followed by 30 cycles of PCR (45 sec at 728C, 45 sec at 948C, 45 sec at 658C); the samples were incubated afterwards for 5 min at 658C and 10 min at 728C (Delabesse et al., 1995) . After migration on an ABI sequencer using 10% denaturing polyacrylamide gel, fluorescent peaks were quantified with the software Gene Scan analysis (Applied Biosystems).
To perform methylation analysis, DNA samples were digested with the methylation sensitive enzyme HpaII for 4 h at excess concentrations (10 U/mg of DNA) using the manufacturer's recommendations (Gibco). Samples were subsequently divided in two equal fractions and amplified by PCR as above. The HpaII predigestion precludes the PCR amplification of the non-methylated digested DNA, therefore the amplification will occur from methylated (inactive) alleles only. The presence of both methylated and unmethylated DNA after HpaII digestion suggests the presence of cells with both active and inactive HUMARA alleles in the sample.
In order to amplify DNA from single hematopoietic colonies, we used nested PCR, by performing a first round of amplification using external primers first. These primers were ARA sense oligonucleotide 5 ′ -GAG GCG GGG TAA GGG AAG TA-3 ′ and ARA antisense oligonucleotide 5 ′ -GCG GCT GTG AAG GTT GCT GT-3 ′ . PCR was performed using the same conditions as above. Using a second round of amplification, 1/500th of the PCR product was then used using the primers described above.
Data interpretation
The expected size of the PCR product is 210 bp, depending on the number of CAG repeats present in the polymorphic region of the HUMARA gene. In the informative samples, two peaks are detected. The mean fluorescent peak is preceded by small stepwise peaks thought to be related to the slipping of the enzyme from the target sequence during the amplification procedure. When the same analysis is performed after digestion of DNA with a methylation sensitive enzyme HpaII, if the methylated alleles are contributed by the cells with the same XCI pattern, one peak is totally digested, generating a 'clonal' pattern that is seen usually in tumor samples such as the positive control that we have used in this study (Figure 3) . Quantification of the presence of methylated versus unmethylated alleles was performed using the RCI, which was obtained by dividing the ratio of the area under the peaks in the undigested sample (A/B) by the ratio of the two peaks (A ′ /B ′ ) in the digested samples. When the sample contains a balanced ratio of undigested/digested alleles, this ratio is close to 1. In case of a contribution of exclusively methylated (or unmethylated) alleles in the sample, there is a total digestion of one allele by HpaII and a 'clonal pattern' is obtained with an RCI value which tends to the infinite in case of total digestion. For practical purposes we have considered that a sample contained cells with total methylated or unmethylated alleles (Xi or Xa), when the RCI was .10. When this value was ,2, we considered the sample containing a balanced ratio of unmethylated/methylated alleles. When the value was between 2 and 10, the sample contained an excess of methylated or unmethylated alleles. In previous experiments we have shown that the sensitivity of this technique is 10% as estimated by dilution experiments of different clonal cell populations (Delabesse et al., 1995) .
